Skip to main content

Respiration Rate

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Masimo
MasimoIRVINE, CA
1 program
INVSENSOR00004N/A1 trial
Active Trials
NCT03482505Terminated10Est. Aug 2018
Philips
PhilipsNetherlands - Amsterdam
1 program
VSC-MEDlibN/ASmall Molecule1 trial
Active Trials
NCT06140433Completed94Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsVSC-MEDlib
MasimoINVSENSOR00004

Clinical Trials (2)

Total enrollment: 104 patients across 2 trials

Vital Signs Camera Study

Start: Feb 2024Est. completion: Mar 202494 patients
N/ACompleted
NCT03482505MasimoINVSENSOR00004

Rainbow Acoustic Monitoring (RAM) in Patients Weighing up to 10kg Comparison Study

Start: Mar 2018Est. completion: Aug 201810 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.